This is just the start for Florida’s leading cannabis company…

It was the first cannabis company in Florida.

It was the first to be able to deliver to its customers at scale.

It’s licensed to open more storefronts than any other cannabis company is legally allowed to operate.

And it just keeps breaking its own records.

In June, Trulieve Cannabis Corp. (OTC: TCNNF) celebrated the opening of its 50th Florida dispensary.

The company then topped its own milestone last week with yet another location, bringing the total to a record 51 dispensaries in the Sunshine State.

That’s not all, either.

Trulieve’s unparalleled growth continues to separate it even further from its competitors – making it an impressive case study in how cannabis companies can achieve total market domination.

So, today, we’re breaking down five ways Trulieve is securing its status as the leading company in one of the biggest medical markets in the country…

1. The $2.5 Billion Opportunity in Florida

Let’s start with the simple fact that Florida is one of the fastest-growing medical cannabis markets in the United States, with an average of 609 new patients registering every day in 2019.

Today, the state boasts over 361,000 patients thanks in part to a large population, an older demographic now looking to cannabis as a wellness product, and more stringent rules on prescribing opioids in Florida.

That means more doctors are looking to medical cannabis as medicine.

With legalization inevitably passing in the next few years, Florida could be the largest adult-use cannabis market in the U.S. by 2025, with an estimated $2.5 billion in legal cannabis sales expected that year.

And with its first-mover advantage, Trulieve is ready to claim the lion’s share of that opportunity.

2. A Critical First-Mover Advantage

Trulieve was the first medical cannabis operator in Florida, giving it the all-important first-mover advantage and an early jump on the competition.

A first-mover advantage doesn’t necessarily define whether a company will be successful, but in this case, it played a significant role in cementing Trulieve’s brand recognition and loyalty across Florida’s medical marijuana patient base.

Today, well over half of all cannabis products sold in Florida are Trulieve products.

And it’s because of this first-mover advantage that CEO Kim Rivers was able to make a critical legal move that would secure this company’s status as Florida’s top cannabis brand.

3. More Licenses Than Any Other Retailer

Florida’s medical market uses a limited license program in which the number of dispensary licenses companies are allowed to obtain is dependent on the number of patients in the state.

But by the time a 35-license cap was put into law in 2017, Kim had already opened her first 14 dispensary locations. So, she took it to court, arguing that those 14 licenses shouldn’t count toward Trulieve’s cap because they had been obtained prior to the law being established.

She won. And Trulieve can now operate more dispensaries than any other retailer is legally allowed to, which means putting more of its products in front of more customers than any other competitor.

4. The First Brand to Sell Flower in Florida

The licensing win was a major one, but that wasn’t the only time Trulieve’s leadership went to bat for the company and came out on top.

When it was first passed, Florida’s medical program did not allow for smokable cannabis products. For Trulieve, that wasn’t good enough.

The ban was challenged and finally lifted in 2019 – and Trulieve was the very first retailer to sell smokable cannabis products at its dispensaries, further strengthening its brand recognition in the state.

5. This Is Just the Start for Trulieve

Today, Trulieve is in a strong, cash-rich financial position thanks to strategic decisions by its leadership team.

And between having plenty of cash on hand and Kim’s extensive background in navigating mergers and acquisitions (M&As), Trulieve has been able to expand into two new states – Massachusetts and California.

On its current trajectory, Trulieve is projecting revenue of $400 million for 2021. A potential COVID-19 recession won’t hamper that; and with a few more acquisitions, it could get to $700 million in 2022.

As one of the only profitable cannabis companies out there right now, this is the kind of pot stock you want in your portfolio.

Executive Director Don Yocham has 10 other incredible cannabis companies listed in his Cannabis Moonshot Model Portfolio that you need to know about today.

Access the full list of Don’s top 10 pot stock recommendations for under $10 per share right here.

Take care,


Comments

10 responses to “5 Reasons Trulieve Could Be the Top Cannabis Company in the Country”

    • Hi Robert,

      These are some of the brokerages our members use and their customer service numbers are included to help you get started:
      eTrade 1 (800) 387-2331
      Fidelity – 1 (800) 343-3548
      TDAmeritrade – 1 (800) 669-3900

      Once you have a brokerage account set up and have funded it, you can start searching for stocks by company name or ticker symbol.

    • Hi Michael,

      Liberty Health currently has 27 dispensaries that are either open or about to be opened listed for its footprint in Florida, so it is certainly growing its presence.

  1. Wonderful. I have 500 shares of Trulieve so I am very excited and happy to hear the good news. Of course, I see it rising in my portfolio . I really enjoy the news when Don Yocham writes his column.
    I listen and learn from him.
    Keep it up Don and thank you.
    Susan Richmond

  2. I have been a lifetime member since NICI started in 2018.
    The Cannabis market is very volatile, and I highly recommend that you
    use the NICILytics and study the stocks that are listed as a 5.
    Example: I used to own a stock that was a 5 and dropped to a 3, and so
    I sold it at a loss. I recommend E-Trade as I have been very happy and
    pleased with their performance, and they can teach via online or contact
    a trader, they are very helpful and LEGIT ! NICI is growing, and doing a
    much better job of communicating with members, now that Don Yocham has joined the group. Thanks Don, for the FYI and valued info. Good Job!

  3. Personally I think Liberty Health Sciences is a much better buy in the Florida market .
    Grossly undervalued & profitable with
    a good amount of cash on the balance sheet.

  4. Would appreciate any inputs on MedMen Enterprises—who is working what appears to be a solid turnaround plan. Stock has been terrible …for many reasons…and one of them no earnings yet. All new senior management , company founders are gone and new board members—all positive.

Leave a Reply

Your email address will not be published. Required fields are marked *